Get the Stockscreener App
17.69
5.99%
1.00
After Hours:
17.60
-0.09
-0.51%
Procept Biorobotics Corp stock is traded at $17.69, with a volume of 1.34M.
It is up +5.99% in the last 24 hours and down -21.59% over the past month.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
See More
Previous Close:
$16.69
Open:
$16.97
24h Volume:
1.34M
Relative Volume:
0.84
Market Cap:
$1.01B
Revenue:
$322.02M
Net Income/Loss:
$-102.47M
P/E Ratio:
-9.6693
EPS:
-1.8295
Net Cash Flow:
$-80.57M
1W Performance:
-7.96%
1M Performance:
-21.59%
6M Performance:
-42.53%
1Y Performance:
-68.25%
1-Day Range:
$16.86
$18.14
1-Week Range:
$16.66
$19.09
52-Week Range:
$16.66
$56.87
Procept Biorobotics Corp Stock (PRCT) Company Profile
Name
Procept Biorobotics Corp
Sector
Industry
Phone
(650) 232-9832
Address
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
17.69 | 949.98M | 322.02M | -102.47M | -80.57M | -1.8295 |
ABT
Abbott Laboratories
|
104.49 | 179.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
336.74 | 126.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
84.22 | 106.51B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
45.51 | 65.77B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.04 | 47.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Initiated | Robert W. Baird | Neutral |
| Feb-26-26 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-26-26 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-12-25 | Initiated | UBS | Buy |
| Dec-08-25 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-02-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-09-25 | Initiated | Stephens | Overweight |
| Jul-07-25 | Initiated | Oppenheimer | Perform |
| Dec-02-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Initiated | Jefferies | Hold |
| Aug-11-23 | Initiated | Piper Sandler | Overweight |
| May-31-23 | Initiated | William Blair | Outperform |
| Oct-31-22 | Initiated | BTIG Research | Neutral |
| Oct-25-22 | Initiated | Truist | Buy |
| Sep-02-22 | Initiated | Wells Fargo | Overweight |
| Jul-15-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Oct-11-21 | Initiated | Cowen | Outperform |
| Oct-11-21 | Initiated | Goldman | Neutral |
| Oct-11-21 | Initiated | Guggenheim | Buy |
| Oct-11-21 | Initiated | SVB Leerink | Outperform |
View All
Procept Biorobotics Corp Stock (PRCT) Latest News
PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit - PR Newswire
INVESTOR ALERT: Securities Class Action Filed Against PROCEPT BioRobotics Corporation – Investors Encouraged to Contact Kirby McInerney LLP - Business Wire
PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock DeclineInvestors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC - marketscreener.com
Law Offices of Howard G. Smith Encourages PROCEPT BioRobotics Corporation (PRCT) Shareholders To Inquire About Securities Fraud Class Action - WBOC TV
Rosen Law Firm Urges PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Stockholders to Contact the Firm for Information About Their Rights - Business Wire
Notice to Long-Term Shareholders of Cogent Communications - GlobeNewswire
Notice to Long-Term Shareholders of Cogent Communications Holdings, Inc. (NASDAQ: CCOI); EquipmentShare.com, Inc. (NASDAQ: EQPT); Photronics, Inc. (NASDAQ: PLAB); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Office is Investigating Claims on Your Behalf - GlobeNewswire Inc.
Class action lawsuit filed against PROCEPT BioR... - Pluang
PROCEPT BIOROBOTICS CORPORATION (PRCT) INVESTOR ALERT - GlobeNewswire
Procept BioRobotics faces class action lawsuit over inflated sales and undisclosed inventory issues. - Pluang
PRCT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against PROCEPT BioRobotics Corporation and Announces Opportunity for Investors with Substantial Losses to Lead the Procept Class Action Lawsuit - PR Newswire
INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Intuit Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
Class action lawsuit alleges PROCEPT BioRobotics inflated revenue via aggressive discounting. - Pluang
Procept BioRobotics: Filling Robots Slower Than Placing Them (NASDAQ:PRCT) - Seeking Alpha
Procept Biorobotics Corp (PRCT) Cash Flow - TradingKey
Procept Biorobotics Corp (PRCT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit with the Schall Law Firm - The Daily Tribune News
Procept Biorobotics Corp (PRCT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PRCT|Procept Biorobotics Corp|Price:17.250|Chg%:+0.560 - TradingKey
Procept Biorobotics Corp. (PRCT) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Procept Biorobotics Corp. (PRCT) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
TradingKey - TradingKey
PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Who Suffered Losses May Be Eligible to Participate in Securities Class Action; Contact Robbins LLP for Information About Recovering Your Losses - The AI Journal
PRCT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files - GlobeNewswire
PRCT|Procept Biorobotics Corp|Price:16.690|Chg%:-0.860 - TradingKey
Procept Biorobotics stock hits 52-week low at $17.95 - Investing.com
PROCEPT BioRobotics Corporation (PRCT): Investor Outlook on a Potential 52% Upside in the Healthcare Sector - DirectorsTalk Interviews
PROCEPT BioRobotics (PRCT) Gains On Coverage And Trial Progress, Is The Stock Still Cheap? - Sahm
Mobia Medical (MOBI) names ex-PROCEPT CEO Reza Zadno as director - Stock Titan
Procept Biorobotics Corp stock hits 52-week low at 19.2 USD - Investing.com Nigeria
PROCEPT BioRobotics to report Q2 2026 results on August 4 - scanx.trade
Procept Biorobotics Corp stock hits 52-week low at 19.2 USD By Investing.com - Investing.com South Africa
PROCEPT BioRobotics® to Report Second Quarter 2026 Financial Results on August 4th, 2026 - The Manila Times
PROCEPT BioRobotics to Report Second Quarter 2026 Financial Results on August 4th, 2026 - Moomoo
PRCT Stock Tumbles Pre-Market: BofA Questions Earnings Visibility, Cuts Target To $20 - Stocktwits
Procept BioRobotics shares slide after Leerink downgrade cites rising competitive risks - MSN
Pooja Sharma Net Worth (2026) - GuruFocus
Truist Financial Sticks to Its Hold Rating for PROCEPT BioRobotics (PRCT) - The Globe and Mail
PROCEPT BioRobotics stock stays guided by procedure demand - AD HOC NEWS
Truist Downgrades PROCEPT BioRobotics to Hold From Buy, Lowers Price Target to $25 From $30 - marketscreener.com
PRCTProcept BioRobotics Corp Dividends - Finviz
Truist cuts Procept BioRobotics stock rating on reimbursement concerns By Investing.com - Investing.com Nigeria
Truist cuts Procept BioRobotics stock rating on reimbursement concerns - Investing.com
Truist Securities downgraded the stock rating of PROCEPT BioRobotics Corp from "Buy" to "Hold" - Bitget
PROCEPT BioRobotics Jumps 3.94%: Key Levels for PRCT StockEarly Entry Signals - dars.gov.et
PROCEPT BioRobotics (PRCT) Is Up 7.2% After WATER IV Milestones Spotlight Aquablation’s Oncology Potential – Has The Bull Case Changed? - simplywall.st
Evercore Initiates PROCEPT BioRobotics (PRCT) At “Outperform,” Cites Aquablation Growth Potential - Insider Monkey
Price to book forward of PROCEPT BioRobotics Corporation – NASDAQ:PRCT - TradingView
Price to sales forward of PROCEPT BioRobotics Corporation – NASDAQ:PRCT - TradingView
Enterprise value to EBITDA forward of PROCEPT BioRobotics Corporation – NASDAQ:PRCT - TradingView
Price to sales forward of PROCEPT BioRobotics Corp. – BX:PRCT - TradingView
Procept Biorobotics Corp Stock (PRCT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.79%
4.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):